Recombinant human insulin-like growth factor I (rhIGF I) reduces hyperglycaemia in patients with extreme insulin resistance

Diabetologia

Volumn 34, Issue 9, 1991, Pages 675-679

  Schoenle, E J ^a,b   Zenobi, P D ^a   Torresani, T ^a   Werder, E A ^a   Zachmann, M ^a   Froesch, E R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

acanthosis nigricans; IGF I administration; insulin receptor; insulin like growth factor I; Type A insulin resistance

Indexed keywords

C PEPTIDE; GLUCOSE; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CASE REPORT; FEMALE; GROWTH HORMONE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KINETICS; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T; SYNDROME;

EID: 0025822886     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00400998     Document Type: Article

References (28)

1. The syndromes of insulin resistance and acanthosis nigricans. Insulin receptor disorders in man
2. Demonstration of a primary (genetic?) defect in insulin receptors in fibroblasts from a patient with the syndrome of extreme insulin resistance
3. Insulin receptor biosynthesis in cultured lymphocytes from insulin resistant patients
4. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans and the polycystic ovary syndrome (Type A insulin resistance)
5. Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing
6. Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor
7. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor
8. Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance
9. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin
10. Insulin-like growth factor I and II: Some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulinlike activity of human serum
11. Insulin-like growth factor I stimulates growth in hypophysectomized rats
12. Actions of insulin-like growth factors
13. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro
14. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
15. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects
16. Insulin-like growth factors and insulin: comparative aspects
17. Insulin and nonsuppressible insulinlike activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart
18. Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycaemia
19. Regulation of binding proteins for insulin-like growth factors in humans
20. Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin
21. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein
22. Radioimmunological determination of human C-peptide in serum
23. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects
24. The insulin receptor: Molecular biology and transmembrane signalling
25. Insulin receptor structure and function in normal and pathological conditions
26. Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats
27. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
28. Therapeutic potential of insulin-like growth factor I